Venture Lending & Leasing VI and Venture Lending & Leasing II retained Gerbsman Partners to solicit interest in acquiring AxioMed’s assets, including the company’s intellectual property.
Cleveland-based AxioMed develops next-generation technology for the cervical and lumbar spine. The company’s Freedom Technology is a next-generation elastomeric-based total disc replacement — a projected multi-billion dollar market opportunity. The platform is on track to capture around $1 million over the next year in the European Union.
Thomas McNearney & Partners, Investors Growth Capital, MB Ventures and Primus are AxioMed Spine’s lead investors. The company has eight United States patents and three patents pending.
More articles on orthopedic devices:
OrthoWorx marks 5th anniversary
Zimmer purchases biologic therapeutics company ETEX
NuVasive grows globally, opens European Center of Excellence
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
